Analyst Research

Report Title Price
Thomson Reuters Stock Report - KISSEI PHARMACEUTICAL COMPANY LIMITED (4547-TO)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Kissei Pharmaceutical Co., Ltd. (4547) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
Kissei Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Wright Investors Service Comprehensive Report for Kissei Pharmaceutical Company Limited
Provider: Wright Reports
$460.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

R&I Affirms Rating on Kissei Pharmaceutical Co., Ltd. at "A-"; Rating Outlook Stable


Thursday, 2 Feb 2012 12:01am EST 

Rating and Investment Information, Inc. announced that it has affirmed the rating on Kissei Pharmaceutical Co., Ltd. at "A-". The rating outlook is stable. 

Latest Developments for Kissei Pharmaceutical Co Ltd

Latest Key Developments in Pharmaceuticals

Company Quote

Kissei Pharmaceutical Co Ltd
(4547.T)
2060.0
45.0 +2.23%
24 May 2013